Normoglycemia in Nondiabetic African Americans hospitalized with heart failure

American Journal of the Medical Sciences

Volumn 338, Issue 4, 2009, Pages 255-258

  Shook, Marshall S ^a   Zafarullah, Haris ^a   Nelson, Maeda D ^a   Bhattacharya, Syamal K ^a   Davis, Richard C ^a   Newman, Kevin P ^a   Weber, Karl T ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Diabetes; Heart failure; Magnesium; Serum glucose; Zinc

Indexed keywords

GLUCOSE; MAGNESIUM; ZINC;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPOMAGNESEMIA; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; TRICUSPID VALVE REGURGITATION; ZINC DEFICIENCY;

EID: 70350172814     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181b272c7     Document Type: Article

References (35)

1. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin 2001;17:107-124
2. Barsheshet A, Garty M, Grossman E, et al. Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure. Arch Intern Med 2006;166:1613-1619
3. Newton JD, Blackledge HM, Squire IB. Ethnicity and variation in prognosis for patients newly hospitalised for heart failure: a matched historical cohort study. Heart 2005;91:1545-1550
4. Newton JD, Squire IB. Glucose and haemoglobin in the assessment of prognosis after first hospitalisation for heart failure. Heart 2006;92: 1441-1446
5. Suskin N, McKelvie RS, Burns RJ, et al. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J 2000;21:1368-1375
6. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;355:773-778
7. Fox CH, Mahoney MC, Ramsoomair D, et al. Magnesium deficiency in African-Americans: does it contribute to increased cardiovascular risk factors? J Natl Med Assoc 2003;95:257-262
8. Arroyo M, LaGuardia SP, Bhattacharya SK, et al. Micronutrients in African-Americans with decompensated and compensated heart failure. Transl Res 2006;148:301-308
9. Tosiello L. Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Intern Med 1996;156:1143-1148
10. Rodríguez-Hernández H, Gonzalez JL, Rodríguez- Morán M, et al. Hypomagnesemia, insulin resistance, and non-alcoholic steatohepatitis in obese subjects. Arch Med Res 2005;36:362-366
11. Faure P, Roussel A, Coudray C, et al. Zinc and insulin sensitivity. Biol Trace Elem Res 1992;32:305-310
12. Salgueiro MJ, Krebs N, Zubillaga MB, et al. Zinc and diabetes mellitus: is there a need of zinc supplementation in diabetes mellitus patients? Biol Trace Elem Res 2001;81:215-228
13. Chimienti F, Favier A, Seve M. ZnT-8, a pancreatic beta-cell-specific zinc transporter. Biometals 2005;18:313-317
14. Gyulkhandanyan AV, Lee SC, Bikopoulos G, et al. The Zn2- transporting pathways in pancreatic-cells: a role for the L-type voltage-gated Ca2 channel. J Biol Chem 2006;281:9361-9372
15. Alsafwah S, LaGuardia SP, Nelson MD, et al. Hypovitaminosis D in African Americans residing in Memphis, Tennessee with and without heart failure. Am J Med Sci 2008;335:292-297
16. Ali S, Shahbaz AU, Nelson MD, et al. Reduced relative lymphocyte count in African-Americans with decompensated heart failure. Am J Med Sci 2009;337:156-160
17. Duerinckx AJ, Grant EG, Perrella RR, et al. The pulsatile portal vein in cases of congestive heart failure: correlation of duplex Doppler findings with right atrial pressures. Radiology 1990;176:655-658
18. Anker SD, Chua TP, Ponikowski P, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997;96:526-534
19. Selektor Y, Weber KT. The salt-avid state of congestive heart failure revisited. Am J Med Sci 2008;335:209-218
20. Rizza RA, Cryer PE, Haymond MW, et al. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest 1980;65:682-689
21. Deibert DC, DeFronzo RA. Epinephrine-induced insulin resistance in man. J Clin Invest 1980;65:717-721
22. Swan JW, Walton C, Godsland IF, et al. Insulin resistance in chronic heart failure. Eur Heart J 1994;15:1528-1532
23. Coats AJ, Anker SD. Insulin resistance in chronic heart failure. J Cardiovasc Pharmacol 2000;35:S9 -14.
24. Zafarullah H, Shahbaz AU, Alturkmani R, et al. Elevated serum cobalamin in patients with decompensated biventricular failure. Am J Med Sci 2008;336:383-388
25. Niebauer J, Volk HD, Kemp M, et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999;353:1838-1842
26. Sandek A, Bauditz J, Swidsinski A, et al. Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol 2007;50: 1561-1569
27. Berkowitz D, Croll MN, Likoff W. Malabsorption as a complication of congestive heart failure. Am J Cardiol 1963;11:43-47
28. Jones RV. Fat-malabsorption in congestive cardiac failure. Br Med J 1961;1:1276-1278
29. Egi M, Bellomo R, Stachowski E, et al. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med 2008;36:2249-2255
30. Whitcomb BW, Pradhan EK, Pittas AG, et al. Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations. Crit Care Med 2005;33:2772-2777
31. Freire AX, Bridges L, Umpierrez GE, et al. Admission hyperglycemia and other risk factors as predictors of hospital mortality in a medical ICU population. Chest 2005;128:3109-3116
32. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-1367
33. Van den Berghe G, Wouters PJ, Kesteloot K, et al. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med 2006;34:612-616
34. Swan JW, Anker SD, Walton C, et al. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol 1997;30:527-532
35. Vardeny O, Detry MA, Moran JJ, et al. The-2 adrenergic receptor Gln27Glu polymorphism affects insulin resistance in patients with heart failure: possible modulation by choice of beta blocker. J Cardiovasc Pharmacol 2008;52:500-506